Albemarle Corp (ALB)
NYSE Market Closed
Albemarle Corporation is a global specialty chemicals company best known as one of the world’s leading producers of lithium, a critical material for rechargeable batteries. Demand for lithium is closely linked to electric vehicles, energy storage systems, consumer electronics, and broader electrification trends, making Albemarle an important supplier in the battery materials value chain. The company participates across multiple stages of lithium production, from resource extraction to chemical conversion.
Albemarle’s lithium footprint includes brine resources in Chile and the United States as well as hard-rock spodumene operations in Australia through joint ventures. It operates conversion and refining facilities in several key regions, including Chile, the US, Australia, and China, producing lithium compounds used by battery manufacturers and other industrial customers. This integrated model gives the company exposure to both upstream resource economics and downstream processing demand.
Beyond lithium, Albemarle is also a major producer of bromine-based products. Bromine is used in applications such as flame retardants, specialty chemicals, drilling fluids, and other industrial processes. This business provides diversification outside battery materials and reflects the company’s broader expertise in chemistry and mineral-based production.
Albemarle’s performance is influenced by lithium pricing, electric vehicle adoption, customer contracting, project execution, and regulatory conditions in the countries where it operates. The company stands out for its scale, global resource base, and established relationships with battery and industrial customers. At the same time, it operates in cyclical commodity-linked markets where supply growth, technology changes, and end-market demand can significantly affect profitability.
Last updated
- Market Cap
- $13,851,424,760
- P/E
- —
- P/FCF
- 23.99
- P/S
- 2.52
- Enterprise Value
- $14,643,446,760
- Sector
- Materials
- Industry
- Specialty Chemicals
- Address
- 4250 CONGRESS STREET, CHARLOTTE, NC, 28209
Is Albemarle Setting Up for a Lithium-Fueled Rebound?
Bromine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031
Albemarle: Analysts Turn Bullish as Lithium Prices Rise
Oilfield Chemicals Market is expected to generate a revenue of USD 38.09 Billion by 2031, Globally, at 5.31% CAGR: Verified Market Research®
AI Is Changing the Lithium Market: 2 Stocks That Can Lead
Why US Government Is Backing Domestic Lithium Firms and How to Follow the Rally
Lithium Americas Rally Lifts Other Rare Earth Stocks
Chinese Lithium Production Halt Means Upside for These 3 Stocks
Lithium Market to Reach USD 103.42 Billion by 2032 | Demand Fueled by Growth in EV Adoption, Grid Storage, and Battery Manufacturing
Act Fast: These 3 Undervalued Stocks Won’t Stay Low for Long
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- $13,851,424,760
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- $14,643,446,760
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- 1.41
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 2.52
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 13.84
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 2.67
- EPS
- -3.39
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 2.85%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 23.99
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 12.79
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- $577,275,000
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -4.06%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- -2.64%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0.19
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 2.07
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 1.21
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.69
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- $2,434,457
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 117.45
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 1.43B | 1.43B | 1.31B | 1.33B | 1.08B |
| Cost of revenue | 927.77M | 1.23B | 1.19B | 1.13B | 920.58M |
| Gross profit | 500.97M | 197.93M | 117.61M | 196.88M | 156.3M |
| Operating income | 328.52M | -217.39M | -216.99M | 47.53M | 19.76M |
| EBITDA | 512.2M | 193.96M | 130.84M | 220.71M | 180.45M |
| Net income | 277.4M | -455.87M | -202.38M | -18.79M | -340K |
| Income taxes | 21.51M | 157.33M | -30.57M | 34.09M | -3.98M |
| Interest expense | -33.12M | -57.78M | -50.96M | -49.94M | -48.98M |
| Other operating expenses | 25.87M | 247.64M | 183.35M | 4.45M | -1.06M |
| Total operating expenses | 172.44M | 415.32M | 334.6M | 149.35M | 136.54M |
| Basic EPS | 2.35 | -3.88 | -1.72 | -0.16 | — |
| Diluted EPS | 2.34 | -3.88 | -1.72 | -0.16 | — |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 15.14B | 16.37B | 17.15B | 17.29B | 17B |
| Total liabilities | 5.03B | 6.59B | 6.88B | 6.79B | 6.72B |
| Total equity | 10.11B | 9.78B | 10.27B | 10.5B | 10.27B |
| Cash & equivalents | 1.09B | 1.62B | 1.93B | 1.81B | 1.52B |
| Current assets | 3.26B | 4.01B | 4.55B | 4.51B | 4.11B |
| Current liabilities | 1.58B | 1.67B | 2B | 1.95B | 1.94B |
| Accounts payable | 677.15M | 779.16M | 780.38M | 737.32M | 778.66M |
| Receivables | 659.48M | 698.61M | 841.18M | 879.74M | 807.86M |
| Inventories | 1.35B | 1.18B | 1.53B | 1.64B | 1.66B |
| Goodwill | 1.49B | 1.5B | 1.49B | 1.67B | 1.61B |
| Long-term debt | 1.81B | 3.12B | 3.18B | 3.18B | 3.13B |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 346.24M | 388.49M | 355.6M | -7.2M | 547.21M |
| Investing cash flow | 540.96M | -176.64M | -152.98M | 362.92M | -129.06M |
| Financing cash flow | -1.41B | -533.02M | -90.53M | -90.63M | -120.01M |
| Change in cash | -528.19M | -313.76M | 124.93M | 288.32M | 326.28M |
| Net income | 328.98M | -401.76M | -147.94M | 35.19M | 49.3M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| form 4 | Form 4 — STEINER GERALD A | View Filing | |
| form 4 | Form 4 — STEINER GERALD A | View Filing | |
| form 4 | Form 4 — BRLAS LAURIE | View Filing | |
| form 4 | Form 4 — BRLAS LAURIE | View Filing | |
| form 4 | Form 4 — BRLAS LAURIE | View Filing | |
| form 4 | Form 4 — MINOR GLENDA J | View Filing | |
| form 4 | Form 4 — Widmar Mark R | View Filing | |
| form 4 | Form 4 — Van Deursen Holly | View Filing | |
| form 4 | Form 4 — Wolff Alejandro Daniel | View Filing | |
| form 4 | Form 4 — Wolff Alejandro Daniel | View Filing | |
| form 4 | Form 4 — OConnell Diarmuid B. | View Filing | |
| form 4 | Form 4 — OConnell Diarmuid B. | View Filing | |
| form 4 | Form 4 — Cramer Ralf Hans | View Filing | |
| form 4 | Form 4 — Cramer Ralf Hans | View Filing | |
| form 4 | Form 4 — Cramer Ralf Hans | View Filing | |
| form 4 | Form 4 — Cramer Ralf Hans | View Filing | |
| form 4 | Form 4 — Collins Michelle T | View Filing | |
| form 4 | Form 4 — Collins Michelle T | View Filing | |
| edgar index | 11-K — ALBEMARLE CORP | View Filing | |
| edgar index | 8-K — ALBEMARLE CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SD — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| edgar index | 144 — ALBEMARLE CORP | View Filing | |
| form 4 | Form 4 — Masters J Kent | View Filing | |
| form 4 | Form 4 — Masters J Kent | View Filing | |
| form 4 | Form 4 — Masters J Kent | View Filing | |
| edgar index | SCHEDULE 13G/A — ALBEMARLE CORP | View Filing | |
| edgar index | 8-K — ALBEMARLE CORP | View Filing | |
| edgar index | S-8 — ALBEMARLE CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — ALBEMARLE CORP | View Filing | |
| edgar index | 10-Q — ALBEMARLE CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G — ALBEMARLE CORP | View Filing | |
| edgar index | SCHEDULE 13G — ALBEMARLE CORP | View Filing | |
| edgar index | 8-K — ALBEMARLE CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| form 4 | Form 4 — Wolff Alejandro Daniel | View Filing | |
| edgar index | 10-K/A — ALBEMARLE CORP | View Filing | |
| edgar index | SCHEDULE 13G/A — ALBEMARLE CORP | View Filing | |
| edgar index | 8-K — ALBEMARLE CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | DEF 14A — ALBEMARLE CORP | View Filing | |
| edgar index | DEFA14A — ALBEMARLE CORP | View Filing | |
| edgar index | ARS — ALBEMARLE CORP | View Filing | |
| edgar index | S-3ASR — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| form 4 | Form 4 — Masters J Kent | View Filing | |
| edgar index | PRE 14A — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| edgar index | 144 — ALBEMARLE CORP | View Filing | |
| form 4 | Form 4 — Masters J Kent | View Filing | |
| form 4 | Form 4 — Masters J Kent | View Filing | |
| form 4 | Form 4 — Masters J Kent | View Filing | |
| edgar index | 8-K — ALBEMARLE CORP | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing | |
| edgar index | 4 — ALBEMARLE CORP | View Filing |
- Trusted by 1M+ investors
- Global coverage
- Real-time market data
- Independent & unbiased
Join thousands making smarter investment decisions.
Get started for free